Cancer clinical trials
Showing 101–150 of 343 active trials. Describe your situation to see which ones you may be eligible for.
- A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
- Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
- EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
- Vincere Biobank Research Protocol
- Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
- Ovarian Tissue Cryopreservation for Fertility Preservation
- Prospective Study of oncRNA Stratification of Cancer by Size and Stage
- MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)
- Multi-Cancer Early Detection (MCED) of Firefighters
- Young Adult Infusion Space Experience Satisfaction Survey
- Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
- The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
- Cancer Clinical Trials Financial Reimbursement Program
- The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
- Patient Derived Preclinical Models
- Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
- Avera Cancer Sequencing and Analytics Protocol (ASAP)
- UNC Childhood, Adolescent, and Young Adult Cancer Cohort
- Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors
- BostonGene-Integrated Genomic Registry (BIGR)
- Prevent Cancer- Greenville
- Morehouse Total Cancer Care Protocol
- Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
- Connect for Cancer Prevention Study (Connect)
- Proton Radiation Therapy Registry
- Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
- Molecular Genetics Studies of Cancer Patients and Their Relatives
- Autoimmunity After Checkpoint Blockade
- Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
- Strategic Targeting for Optimal Prevention of Cancer
- A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
- A Crowd Sourcing Platform for Patients With Cancer
- Food and Microbiome Longitudinal Investigation (FAMiLI)
- Inherited CAncer REgistry
- Norris ORIEN Total Cancer Care
- Proton Therapy Patient Registry
- Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- Study of Personalized Cancer Therapy to Determine Response and Toxicity
- Intra- and Inter-fraction Changes in Radiation Therapy
- Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
- Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
- Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
- Caris Biorepository Research Protocol
- Long-Term Follow-Up of Recipient of Gene Transfer Research
- Arizona Cancer Center Biospecimen Repository
- Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.